MedTrace Logo

Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere

NCT06400914 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2025-08-15

Study results available
· View outcomes & findings →

Summary

The aim of this study is to compare the short-term clinical performance of two sphere contact lenses.

Conditions

  • Ametropia

Interventions

DEVICE

Lens A (ocufilcon D)

15 minutes of daily wear.

DEVICE

Lens B (fanfilcon A)

15 minutes of daily wear.

Sponsors & Collaborators

  • Centre for Ocular Research & Education, Canada

    collaborator OTHER

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Ruben Guerrero, MSc, FIACLE · National Autonomous University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-03
Primary Completion
2024-05-11
Completion
2024-05-11
FDA Device
Yes

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06400914 on ClinicalTrials.gov